We are live on ! Find out more
ACP

Ashfield Capital Partners Portfolio holdings

AUM $1.19B
1-Year Est. Return 14.56%
This Fund
S&P 500
This Quarter Est. Return
+8.97%
1 Year Est. Return
-14.56%
3 Year Est. Return
+48.8%
5 Year Est. Return
+97.38%
10 Year Est. Return
AUM
$892M
AUM Growth
+$91M
Cap. Flow
+$26.1M
Cap. Flow %
2.93%
Top 10 Hldgs %
28.29%
Holding
255
New
5
Increased
56
Reduced
113
Closed
8

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$8.81M
2
ILMN icon
Illumina
ILMN
+$8.5M
3
AMZN icon
Amazon
AMZN
+$4.21M
4
UNH icon
UnitedHealth
UNH
+$3.32M
5
MSFT icon
Microsoft
MSFT
+$3.09M

Sector Composition

Rank Sector Weight
1 Technology 22.05%
2 Healthcare 18.56%
3 Industrials 10.51%
4 Consumer Discretionary 10.42%
5 Communication Services 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXD
51
DELISTED
Pioneer Natural Resource Co.
PXD
$4.66M 0.52%
26,756
+1,131
+4% +$202K
IBB icon
52
iShares Biotechnology ETF
IBB
$9.36B
$4.63M 0.52%
37,954
-3,271
-8% -$385K
NFLX icon
53
Netflix
NFLX
$298B
$4.62M 0.52%
123,380
-1,150
-0.9% -$41.7K
FDX icon
54
FedEx
FDX
$73.2B
$4.56M 0.51%
18,921
+4,041
+27% +$978K
VTI icon
55
Vanguard Morningstar Total Stock Market ETF
VTI
$661B
$4.52M 0.51%
30,175
+94
+0.3% +$13.8K
SWK icon
56
Stanley Black & Decker
SWK
$14.4B
$4.51M 0.51%
30,790
-953
-3% -$136K
SLB icon
57
SLB Ltd
SLB
$73.6B
$4.51M 0.51%
73,959
-3,230
-4% -$208K
CERN
58
DELISTED
Cerner Corp
CERN
$4.34M 0.49%
67,440
-3,171
-4% -$202K
SYK icon
59
Stryker
SYK
$125B
$4.33M 0.49%
24,360
-392
-2% -$66.9K
EXPD icon
60
Expeditors International
EXPD
$22.1B
$4.3M 0.48%
58,472
-374
-0.6% -$27.6K
RSP icon
61
Invesco S&P 500 Equal Weight ETF
RSP
$97.2B
$4.24M 0.48%
39,734
-207
-0.5% -$21.9K
ADP icon
62
Automatic Data Processing
ADP
$106B
$4.21M 0.47%
27,922
+218
+0.8% +$30.8K
CELG
63
DELISTED
Celgene Corp
CELG
$4.17M 0.47%
46,636
-962
-2% -$85K
BABA icon
64
Alibaba
BABA
$292B
$4.14M 0.46%
25,127
+1,646
+7% +$291K
PFE icon
65
Pfizer
PFE
$143B
$4.09M 0.46%
97,840
-579
-0.6% -$22.3K
BKNG icon
66
Booking.com
BKNG
$150B
$3.93M 0.44%
49,575
-1,400
-3% -$110K
ITW icon
67
Illinois Tool Works
ITW
$82.6B
$3.79M 0.42%
26,862
-98
-0.4% -$13.8K
HEDJ icon
68
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.84B
$3.72M 0.42%
117,616
+13,156
+13% +$422K
CRI icon
69
Carter's
CRI
$1.4B
$3.53M 0.4%
35,790
-1,062
-3% -$112K
AWK icon
70
American Water Works
AWK
$27B
$3.47M 0.39%
39,403
-674
-2% -$59.3K
XBI icon
71
State Street SPDR S&P Biotech ETF
XBI
$9.97B
$3.38M 0.38%
35,228
+9,705
+38% +$941K
ORCL icon
72
Oracle
ORCL
$373B
$3.14M 0.35%
60,876
-3,693
-6% -$179K
SBUX icon
73
Starbucks
SBUX
$120B
$3.14M 0.35%
55,183
-2,355
-4% -$125K
AFL icon
74
Aflac
AFL
$65.1B
$3.05M 0.34%
64,751
-1,368
-2% -$62.6K
TJX icon
75
TJX Companies
TJX
$174B
$3.04M 0.34%
54,368
+5,206
+11% +$267K

Similar funds

Ashfield Capital Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Ashfield Capital Partners held 255 positions worth $892M, up 11% from $801M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ashfield Capital Partners's Q3 2018 filing shows 5 new, 56 increased, 113 reduced and 8 closed positions. Its largest new stake was Lockheed Martin: 8,294 shares worth $2.87M. The largest sale was Walgreens Boots Alliance, an estimated $2.64M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Ashfield Capital Partners's largest Q3 2018 buy was Lockheed Martin: 8,294 shares worth $2.87M.
  • Ashfield Capital Partners added most to NVIDIA in Q3 2018, an estimated $8.81M increase.
  • Ashfield Capital Partners's biggest Q3 2018 reduction was Walgreens Boots Alliance, cutting an estimated $2.64M.
  • Ashfield Capital Partners fully exited Lam Research in Q3 2018, selling an estimated $1.04M.
  • Ashfield Capital Partners's ten largest holdings make up 28% of its $892M portfolio in Q3 2018.
  • Ashfield Capital Partners opened 5 new positions and closed 8 in Q3 2018.
  • Ashfield Capital Partners's portfolio value rose 11% quarter-over-quarter to $892M.

Based on Ashfield Capital Partners's 13F filing for Q3 2018, filed 2 Nov 2018.